The Effect of Intrawound Vancomycin Powder in Spine Surgery

Launched by WINDSOR-ESSEX COMPASSIONATE CARE COMMUNITY · Mar 30, 2021

Keywords

ClinConnect Summary

This clinical trial is studying the use of intrawound vancomycin powder in patients undergoing spine surgery. The main goal is to see if applying this antibiotic powder directly into the surgical wound before closing it can help reduce the risk of infections after surgery. Post-surgical infections can lead to serious complications, longer hospital stays, higher medical costs, and a reduced quality of life, so finding effective ways to prevent them is very important.

To participate in this trial, you need to be between the ages of 65 and 74 and require surgery for a spine condition. However, if you have had previous infections at the surgery site, are allergic to vancomycin, or are younger than 18, you won't be eligible. Participants will be randomly assigned to either receive the vancomycin powder or not, and will be followed for at least 12 weeks after their surgery. This trial is currently recruiting, and those who join can expect close monitoring to help assess the effectiveness of this treatment in preventing infections.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients requiring surgery due to any spine disease.
• Exclusion Criteria:
• • A previous history of infections at the spine surgical site.
• • Biopsy procedure.
• • Patients with a postoperative follow-up time of less than 12 weeks.
• • Patients allergic to vancomycin.
• • Patient is less than 18 years old.